5 Key Takeaways
IsoMedica's Commercial
opportunity
Growing demand for alpha isotopes, an integrated supply chain and established commercial relationships position IsoMedica to pursue a significant opportunity in the medical isotope market.

OTher Projects
1. A Growing Market and Supply Gap
Demand for alpha isotopes is increasing, while reliable supply remains constrained. This creates an opportunity for new production capability and a potential first-mover advantage for businesses able to establish a dependable position in the market.
2. A Differentiated, Vertically Integrated Platform
IsoMedica brings together feedstock access, proprietary purification technology and dedicated production infrastructure. Controlling more of the value chain gives entX a differentiated approach and supports its commercial advantage.
3. Processes Designed for Scale and Reliability
IsoMedica’s production processes are being developed with scalability and repeatability in mind. For commercial customers, consistent and reliable supply is critical, making operational execution just as important as the underlying science.
4. Sovereign Capability as a Strategic Advantage
Australia-based production capability offers more than a local supply option. In a constrained market, sovereign infrastructure can provide strategic and regulatory advantages while strengthening the security and reliability of isotope supply.
5. Established Commercial Relationships
With market demand, an integrated production platform and commercial relationships in place, entX is focused on executing the next stage of IsoMedica’s development in 2026.
Through IsoMedica, entX is working to establish a differentiated Australian medical isotope platform and contribute to more reliable global alpha isotope supply.
Moving from Development to Execution
With market demand, an integrated production platform and commercial relationships in place, entX is focused on executing the next stage of IsoMedica’s development in 2026.
Through IsoMedica, entX is working to establish a differentiated Australian medical isotope platform and contribute to more reliable global alpha isotope supply.
